Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

NCT07673016 is registered in ClinicalTrials.gov with Convergent Genomics, Inc. as lead sponsor.

NCT NCT07673016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07673016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
Lead sponsor
Convergent Genomics, Inc.
Phase
Observational
Overall status
Recruiting
Start date
October 15, 2019
Completion date
December 31, 2034
Enrollment
2,500 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, hematuria, upper tract urothelial cancer, urothelial carcinoma (uc)